Evolus Stock

Evolus Enterprise Value

The Enterprise Value (EV) of Evolus (EOLS) as of Aug 8, 2026 is 224.90 M USD. In the previous year, Enterprise Value (EV) was 313.28 M USD — a change of -28.21% (lower).

Enterprise Value

224.90 MUSD

YoY

-28.21%

Last updated:

Enterprise Value (EV) of Evolus is 2026 224.90 M USD. Enterprise Value (EV) of Evolus was 2025 313.28 M USD. It decreases by -28.21% lower compared to the previous year.
Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolus stock

Enterprise Value (EV) of Evolus is 224.90 M USD in 2026.

Enterprise Value (EV) of Evolus changed from 313.28 M USD to 224.90 M USD, representing a -28.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Evolus since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Evolus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Evolus

All Key Metrics — Evolus